MoatScopeSolventum CorporationSOLV
Spin-off from 3M Company (MMM) · Apr 1, 2024 · NYSE
one share of Solventum for every four shares of 3M; at least 80.1% distributed, with 3M retaining up to 19.9%
Documents
Both companies today
Moat ratings, quality scores and fair value estimates are MoatScope research opinions and refresh with the data pipeline. Price / FV below 1.00× means the shares trade under our base-case estimate.
What is being separated
Solventum is 3M's former health care business — medical surgical, dental, health information systems, and purification and filtration products — a global healthcare company built on material science, data science and digital capabilities.
Stated rationale3M said separating health care would create a stand-alone company able to invest in its own growth while 3M focuses on its industrial and consumer businesses.
The four questions
Indiscriminate selling
StrongManagement incentives
PartialThe hidden jewel
PartialLeverage
StrongThe write-up
3M distributed Solventum on April 1, 2024, one Solventum share for every four 3M shares, keeping up to 19.9% of the new company with a stated intention to sell it down. Solventum is 3M's former healthcare business — medical-surgical supplies, dental solutions and health information systems, with a purification and filtration unit that it has since agreed to sell. It issued $6.9 billion of notes and drew $1.5 billion of term loans at separation and paid 3M a cash distribution of about $7.7 billion. On MoatScope's framework Solventum carries a Narrow moat and a quality score of 49 at a $16.0 billion market value, trading at $91.69 against a base-case fair value estimate of $226.98 — 0.41×. 3M carries a Narrow moat and a quality score of 43 at $90.6 billion, 1.08× fair value.
Not investment advice. Terms are as stated in the latest filing; spin-off shares are often thinly covered and volatile in their first months. Write-up dated Sep 8, 2026.